Benitec Biopharma Inc. BNTC
Set alert
8.74 USD -0.09 -1.02%
At close · Oct 30
8.74 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
8.43 Day range 8.93
8.11 52-week range 16.36
- YTD
- -35.12%
- 1 year
- -45.95%
- Open
- 8.80
- Prev close
- 8.83
- Mkt cap
- 304.93M
- Vol
- 135.49K
- Avg vol
- 177.05K
- EPS
- -0.98
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.43
- High
- 8.93
- Forward P/E
- -1.23
- Beta
- 0.88
- Short ratio
- 1.35
- Inst. own
- 82.59%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2025
- 50-d avg
- 10.82
- 200-d avg
- 8.69
- 1y target
- 25.43
Financial health
Altman Z-Score
44.49 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -13.7×
FY 2017 5y median -2.7× FY 2026
P/S 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 3.5×
FY 2017 5y median 4.4× FY 2026
P/FCF -37.5×
FY 2017 5y median -3.8× FY 2026
EV/EBITDA -8.8×
FY 2017 5y median -1.9× FY 2026
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -2.7%
FY 2017 5y median -26.3% FY 2026
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -25.7%
FY 2017 5y median -46.0% FY 2026
ROIC -28.8%
FY 2017 5y median -47.3% FY 2026
ROA -24.9%
FY 2017 5y median -41.7% FY 2026
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2026
Operating Income -22.6%
FY 2017 FY 2026
EPS (diluted) 6.7%
FY 2017 FY 2026
Free Cash Flow 29.6%
FY 2017 FY 2026
Financial Health
Current Ratio 34.0×
FY 2017 5y median 10.5× FY 2026
Quick Ratio 34.0×
FY 2017 5y median 10.5× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 3.5×
FY 2017 5y median 2.3× FY 2026
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-06-30